Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001995218-25-000005

Chief Executive Officer sold 13,133 shares at an average $8.94 ($117,436)

  • Chief Executive Officer acquired 33,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Townsend Richard Nolan · Chief Executive Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-15 Grant or award : show line 1 in the form +33,000 255,251 D
2025-10-17 Sale : show line 2 in the form −12,985 $8.94 $116,021 242,266 D
2025-10-17 Sale : show line 3 in the form −148 $9.56 $1,415 242,118 D
Open-market sales · 13,133 sh · avg $8.94 · $117,436
Loading xslF345X05/form4-10172025_111000.xml…